Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of KH607 for postpartum depression
CTR20252834Phase 2Completed
- Sponsor
- Chengdu Kanghong Pharmaceutical Group
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KH607 in postpartum depression (PPD), sponsored by Chengdu Kanghong Pharmaceutical Group. Started Sep 2025; status: completed.
02
Drugs
KH607
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on CTR20252834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252834.